Neos Therapeutics, Inc. (NEOS) News
Filter NEOS News Items
NEOS News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
NEOS News Highlights
- NEOS's 30 day story count now stands at 11.
- Over the past 9 days, the trend for NEOS's stories per day has been choppy and unclear. It has oscillated between 1 and 7.
- AYTU, ODT and AIM are the most mentioned tickers in articles about NEOS.
Latest NEOS News From Around the Web
Below are the latest news stories about Neos Therapeutics Inc that investors may wish to consider to help them evaluate NEOS as an investment opportunity.
The Daily Biotech Pulse: Sarepta Gene Therapy Data, Idera Plunges On Failed Skin Cancer Study, 3 IPOsHere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 18) AngioDynamics, Inc. (NASDAQ: ANGO ) Anixa Biosciences, Inc. (NASDAQ: ANIX ) ENDRA Life Sciences Inc. (NASDAQ: NDRA ) (announced a collaboration with Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA ) for NASH studies) Harvard Bioscience, Inc. (NASDAQ: HBIO ) Neos Therapeutics, Inc. (NASDAQ: NEOS ) (reacted to the shareholder meeting held to vote on the proposal to merge with Aytu BioScience, Inc. (NASDAQ: AYTU )) NuVasive, Inc. (NASDAQ: NUVA ) SI-BONE, Inc. (NASDAQ: SIBN ) Sierra Oncology, Inc. (NASDAQ: SRRA ) Silverback Therapeutics, Inc. (NASDAQ: SBTX ) Terns Pharmaceuticals, Inc. (NASDAQ: TERN ) Varian Medical Systems, Inc. (NASDAQ: VAR ) Veric... |
Vote Against The Merger Of Neos Therapeutics Inc $NEOSHeadquartered in Grand Prairie, TEXAS, Neos Therapeutics Inc (NEOS) is a pharmaceutical company, develops, manufactures, and commercializes products for the |
NEOS Stock: Neos Therapeutics Climbs on Merger Hopes - CNA FinanceNEOS stock is screaming for the top as investors await the results of a special meeting surrounding a potential merger with AYTU. |
Why Did Aytu Biosciences Gap Up Today? Technical Levels To WatchAytu Biosciences Inc. (NASDAQ: AYTU ) shares gapped up Thursday morning. The price jump is speculatively from the meetings the company is having about the proposed merger with Neos Therapeutics Inc. (NASDAQ: NEOS ). Aytu Short Term Chart Analysis: The 5-minute chart above shows the stock has built higher lows throughout the week and last up to a resistance level of $10. The stock broke out of the resistance level and is now falling back to support. The stock could test the potential support and find a … Full story available on Benzinga.com |
30 Stocks Moving in Thursday's Pre-Market SessionGainers Neos Therapeutics, Inc. (NASDAQ: NEOS) shares rose 58.6% to $1.84 in pre-market trading. Upstart Holdings, Inc. (NASDAQ: UPST) rose 42.6% to $86.71 … |
Why Are Neos Therapeutics, Aytu BioScience Stocks Soaring Today?Neos Therapeutics Inc (NASDAQ: NEOS) and Aytu BioScience Inc (NASDAQ: AYTU) shares are rising today in the premarket session, … |
Thinking about buying stock in Neos Therapeutics, Oriental Culture, Sino-Global Shipping, Bank of America, or Can Fite Biopharma?NEW YORK, March 18, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NEOS, OCG, SINO, BAC, and CANF. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link…. |
Glass Lewis, a Leading Independent Proxy Advisory Firm, Recommends Neos Therapeutics Stockholders Vote “FOR” the Pending Merger With Aytu BioScience– The Neos Therapeutics Board of Directors recommend stockholders vote “FOR” the transaction in advance of the virtual special meeting scheduled for March 18, 2021 at 10:00 a.m. Eastern Time – – Stockholders are encouraged to vote, no matter how many or how few shares they own – – Vote TODAY by telephone, online at www.proxyvote.com, or by mailing proxy card – – MacKenzie Partners, the Company’s proxy solicitor, is available to answer any questions and help stockholders vote their shares – DALLAS and FORT WORTH, Texas, March 12, 2021 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today announced that leading independent proxy advisory firm Glass, Lewis & Co., LLC ... |
Leading Independent Proxy Advisory Firm ISS Recommends Neos Therapeutics Stockholders Vote “FOR” the Pending Merger With Aytu BioScience– The Neos Therapeutics Board of Directors recommend stockholders vote “FOR” the transaction in advance of the virtual special meeting scheduled for… |
Aytu BioScience and Neos Therapeutics Announce Special Meetings of Stockholders Related to Proposed Merger to Be Held on March 18, 2021- Record date for each Special Meeting of Stockholders is February 5, 2021 -\- Upon merger closing, combined company will be renamed Aytu Biopharma, Inc. -ENGLEWOOD, CO and GRAND PRAIRIE, TX / ACCESSWIRE / February 10, 2021 / Aytu BioScience, Inc. |